GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Dipna Pharmachem Ltd

Dipna Pharmachem Appoints Director, Reconstitutes Committees

REGULATORY ◆ Monitor Closely LOW RISK
📅 Filed on BSE: 24 Oct 2026, 04:28 PM IST  ·  BSE ID: 91c436e6-1a2d-4f8a-9daa-a8fa1d63b79d
View Original BSE Filing (PDF)
💡
In Simple Terms
The company appointed a new director and accepted two resignations, then updated its committee memberships.
🤖 AI Summary
  • Dipna Pharmachem appointed Mr. Nirav Soni as Additional Non-Executive Director.
  • Resignations of Independent Directors Mr. Jitendra Parmar and Mr. Manish Bachani accepted.
  • Board reconstituted Audit, Nomination, and Stakeholders committees effective August 10, 2026.
  • Mr. Nirav Soni brings over four years of experience in Marketing and Project Management.
🏢 How This Affects the Company
📈
Business Impact
Changes in directorship and committee composition may influence strategic decisions and governance oversight.
💰
Financial Impact
No direct financial impact is detailed in this filing.
⚙️
Operational Impact
Reconstitution of committees impacts internal governance structures and decision-making processes.
⚠️
Risk Impact
Resignations of independent directors warrant attention regarding board independence and governance continuity.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding these board and committee changes.
👤
Who Is Affected
All shareholders are indirectly affected by changes in board composition and committee oversight.
🔍
Management Signal
The changes signal active management of board composition and committee structures to align with company operations.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Future board meeting outcomes for committee functioning.
Management commentary on strategic direction under new director.
Next quarterly results for operational performance updates.
LOW RISK This filing concerns routine board and committee restructuring, with no immediate financial or operational risks.
💡 Investor Takeaway
Dipna Pharmachem's board appointed Mr. Nirav Soni as Additional Non-Executive Director and accepted resignations of two Independent Directors, reconstituting key committees.
❓ Frequently Asked Questions
Who has been appointed as an Additional Non-Executive Director at Dipna Pharmachem?
Mr. Nirav Madhusudan Soni has been appointed as an Additional Non-Executive and Non-Independent Director.
Who resigned from Dipna Pharmachem's board of directors?
Mr. Jitendra Pradipbhai Parmar and Mr. Manish Shrichand Bachani resigned from their roles as Non-Executive and Independent Directors.
When were the committee changes effective at Dipna Pharmachem?
The reconstitution of the Audit Committee, Nomination and Remuneration Committee, and Stakeholders Relationship Committee is effective from August 10, 2026.
What is the professional background of the newly appointed director?
Mr. Nirav Madhusudan Soni has over four years of experience in Marketing Management, Project Management, and Administrative Operations.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again — explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.